IBM is in the pipeline. Obviously they have deep pockets.
-
-
They're also being helped out by NHGRI grants, although I'm sure that money doesn't go all that far in developing a new technology and instrument to run it:Originally posted by NextGenSeq View Post
"The firm is one of several companies or researchers that have been awarded at least $5.7 million from the National Human Genome Research Institute this year to support their efforts in developing technologies for sequencing a human genome at low cost."
http://www.genomeweb.com//node/92521...1&v=6b1f3d4880 -
3rd article, guess they were stealth for quite a while. Competition is good. Hope they give PacBio a run for the money (thanks forum sponsors!)
Comment
-
The more skeptical amongst you might have noticed that this press release (containing few/no details beyond previous, very old announcements) came out at a similar time to the announcement of the Justice department's anti-trust probe into IBM...Last edited by 454newbie; 03-08-2011, 10:28 AM.Comment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM
Comment